You’re using a public version of DrugPatentWatch with 5 free searches available | Register to unlock more free searches. CREATE FREE ACCOUNT

Last Updated: May 24, 2024

~ Buy the ALCOHOL Drug Excipient Business Development Opportunity Report, 2024 PDF Report in the Report Store ~

Alcohol - Generic Drug Details


✉ Email this page to a colleague

« Back to Dashboard


What are the generic sources for alcohol and what is the scope of freedom to operate?

Alcohol is the generic ingredient in two branded drugs marketed by Bpi Labs and 3M, and is included in two NDAs. Additional information is available in the individual branded drug profile pages.

There are forty-one drug master file entries for alcohol. One supplier is listed for this compound.

Drug Prices for alcohol

See drug prices for alcohol

DrugPatentWatch® Estimated Loss of Exclusivity (LOE) Date for alcohol
Generic Entry Date for alcohol*:
Constraining patent/regulatory exclusivity:
INDICATED TO INDUCE CONTROLLED CARDIAC SEPTAL INFRACTION TO IMPROVE EXERCISE CAPACITY IN ADULTS WITH SYMPTOMATIC HYPERTROPHIC OBSTRUCTIVE CARDIOMYOPATHY WHO ARE NOT CANDIDATES FOR SURGICAL MYECTOMY
Dosage:
SOLUTION;INTRA-ARTERIAL

*The generic entry opportunity date is the latter of the last compound-claiming patent and the last regulatory exclusivity protection. Many factors can influence early or later generic entry. This date is provided as a rough estimate of generic entry potential and should not be used as an independent source.

Recent Clinical Trials for alcohol

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
Assistance Publique - Hôpitaux de ParisPhase 2
Duke UniversityN/A
ACADIA Pharmaceuticals Inc.Phase 2

See all alcohol clinical trials

US Patents and Regulatory Information for alcohol

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
3m AVAGARD alcohol; chlorhexidine gluconate SOLUTION;TOPICAL 021074-001 Jun 7, 2001 OTC Yes Yes ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Bpi Labs ABLYSINOL alcohol SOLUTION;INTRA-ARTERIAL 207987-001 Jun 21, 2018 RX Yes No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Bpi Labs ABLYSINOL alcohol SOLUTION;INTRA-ARTERIAL 207987-002 Jun 21, 2018 RX Yes Yes ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.